Atlas Trials

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction

Clinical trial NCT06061549 · RECRUITING

Trial details

NCT number
NCT06061549
Sponsor
Sardocor Corp.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Heart Failure, DiastolicHeart Failure With Preserved Ejection Fraction
Start date
2023-08-24
Primary completion
2025-08-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.